CLAIM CARD
The human trial landscape for grip strength longevity is dominated by observational cohort studies; randomized controlled trials with hard mortality endpoints are essentially absent. The available evidence derives predominantly from prospective registries linking baseline grip strength to subsequent events. Chair-based exercise interventions have demonstrated significant improvements in grip strength (P < 0.001; Chair-Based 2026), but these trials measure the biomarker, not survival. The heterogeneity of populations—from community-dwelling adults to hospitalized frail elders to pediatric malnutrition cases (Yldz 2026)—complicates generalizability. The question of whether grip strength longevity interventions reduce mortality in any specific subpopulation has not been answered by a single adequately powered RCT.
Evidence grade: exploratory
Contradiction status: none
Publication: 80f030f9-7eeb-47eb-bfb0-2a7392057a72
Provenance: Derivation Web chain
Citation Support
source_1Jayanama 2022source_2TurBoned 2026source_3Karahan 2026source_4Cui 2021source_5Aksoy 2026